These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 24263240

  • 1. Neuropilin 1: function and therapeutic potential in cancer.
    Chaudhary B, Khaled YS, Ammori BJ, Elkord E.
    Cancer Immunol Immunother; 2014 Feb; 63(2):81-99. PubMed ID: 24263240
    [Abstract] [Full Text] [Related]

  • 2. The influence of neuropilin-1 silencing on semaphorin 3A and 3C activity in B16(F10) murine melanoma cells.
    Mazurek AM, Olbryt M.
    Neoplasma; 2012 Feb; 59(1):43-51. PubMed ID: 22082309
    [Abstract] [Full Text] [Related]

  • 3. The VEGF receptor, neuropilin-1, represents a promising novel target for chronic lymphocytic leukemia patients.
    Piechnik A, Dmoszynska A, Omiotek M, Mlak R, Kowal M, Stilgenbauer S, Bullinger L, Giannopoulos K.
    Int J Cancer; 2013 Sep 15; 133(6):1489-96. PubMed ID: 23447383
    [Abstract] [Full Text] [Related]

  • 4. Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis.
    Delgoffe GM, Woo SR, Turnis ME, Gravano DM, Guy C, Overacre AE, Bettini ML, Vogel P, Finkelstein D, Bonnevier J, Workman CJ, Vignali DA.
    Nature; 2013 Sep 12; 501(7466):252-6. PubMed ID: 23913274
    [Abstract] [Full Text] [Related]

  • 5. Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer.
    Battaglia A, Buzzonetti A, Monego G, Peri L, Ferrandina G, Fanfani F, Scambia G, Fattorossi A.
    Immunology; 2008 Jan 12; 123(1):129-38. PubMed ID: 18028372
    [Abstract] [Full Text] [Related]

  • 6. A Neuropilin-1 Antagonist Exerts Antitumor Immunity by Inhibiting the Suppressive Function of Intratumoral Regulatory T Cells.
    Jung K, Kim JA, Kim YJ, Lee HW, Kim CH, Haam S, Kim YS.
    Cancer Immunol Res; 2020 Jan 12; 8(1):46-56. PubMed ID: 31554638
    [Abstract] [Full Text] [Related]

  • 7. Cancer Exacerbates Ischemic Brain Injury Via Nrp1 (Neuropilin 1)-Mediated Accumulation of Regulatory T Cells Within the Tumor.
    Wang L, Zhou Y, Yin J, Gan Y, Wang X, Wen D, Thomson AW, Hu X, Yang L, Stetler RA, Li P, Yu W.
    Stroke; 2018 Nov 12; 49(11):2733-2742. PubMed ID: 30355201
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancer.
    Chuckran CA, Cillo AR, Moskovitz J, Overacre-Delgoffe A, Somasundaram AS, Shan F, Magnon GC, Kunning SR, Abecassis I, Zureikat AH, Luketich J, Pennathur A, Sembrat J, Rojas M, Merrick DT, Taylor SE, Orr B, Modugno F, Buckanovich R, Schoen RE, Kim S, Duvvuri U, Zeh H, Edwards R, Kirkwood JM, Coffman L, Ferris RL, Bruno TC, Vignali DAA.
    Sci Transl Med; 2021 Dec 08; 13(623):eabf8495. PubMed ID: 34878821
    [Abstract] [Full Text] [Related]

  • 9. Neuropilin-1 Acts as a Receptor for Complement Split Products.
    Battin C, De Sousa Linhares A, Paster W, Isenman DE, Wahrmann M, Leitner J, Zlabinger GJ, Steinberger P, Hofer J.
    Front Immunol; 2019 Dec 08; 10():2209. PubMed ID: 31572401
    [Abstract] [Full Text] [Related]

  • 10. Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta.
    Glinka Y, Stoilova S, Mohammed N, Prud'homme GJ.
    Carcinogenesis; 2011 Apr 08; 32(4):613-21. PubMed ID: 21186301
    [Abstract] [Full Text] [Related]

  • 11. Targeting neuropilin-1 interactions is a promising anti-tumor strategy.
    Liu SD, Zhong LP, He J, Zhao YX.
    Chin Med J (Engl); 2020 Nov 09; 134(5):508-517. PubMed ID: 33177389
    [Abstract] [Full Text] [Related]

  • 12. Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity.
    Glinka Y, Prud'homme GJ.
    J Leukoc Biol; 2008 Jul 09; 84(1):302-10. PubMed ID: 18436584
    [Abstract] [Full Text] [Related]

  • 13. Dendritic cells can turn CD4+ T lymphocytes into vascular endothelial growth factor-carrying cells by intercellular neuropilin-1 transfer.
    Bourbié-Vaudaine S, Blanchard N, Hivroz C, Roméo PH.
    J Immunol; 2006 Aug 01; 177(3):1460-9. PubMed ID: 16849452
    [Abstract] [Full Text] [Related]

  • 14. Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.
    Hu B, Guo P, Bar-Joseph I, Imanishi Y, Jarzynka MJ, Bogler O, Mikkelsen T, Hirose T, Nishikawa R, Cheng SY.
    Oncogene; 2007 Aug 16; 26(38):5577-86. PubMed ID: 17369861
    [Abstract] [Full Text] [Related]

  • 15. [Immune semaphorins: involvement of semaphorins in various phases of immune responses].
    Takegahara N, Kumanogoh A.
    Tanpakushitsu Kakusan Koso; 2009 Jun 16; 54(8 Suppl):1101-7. PubMed ID: 21089548
    [No Abstract] [Full Text] [Related]

  • 16. Targeting neuropilin 1 as an antitumor strategy in lung cancer.
    Hong TM, Chen YL, Wu YY, Yuan A, Chao YC, Chung YC, Wu MH, Yang SC, Pan SH, Shih JY, Chan WK, Yang PC.
    Clin Cancer Res; 2007 Aug 15; 13(16):4759-68. PubMed ID: 17699853
    [Abstract] [Full Text] [Related]

  • 17. The semaphorin 4A-neuropilin 1 axis alleviates kidney ischemia reperfusion injury by promoting the stability and function of regulatory T cells.
    Xu J, Li X, Yuan Q, Wang C, Xu L, Wei X, Liu H, Yu B, An Z, Zhao Y, Li X, Zhang X, Ma X, Cai M.
    Kidney Int; 2021 Dec 15; 100(6):1268-1281. PubMed ID: 34534552
    [Abstract] [Full Text] [Related]

  • 18. Novel expression of Neuropilin 1 on human tumor-infiltrating lymphocytes in colorectal cancer liver metastases.
    Chaudhary B, Elkord E.
    Expert Opin Ther Targets; 2015 Feb 15; 19(2):147-61. PubMed ID: 25351619
    [Abstract] [Full Text] [Related]

  • 19. Selective requirements for NRP1 ligands during neurovascular patterning.
    Vieira JM, Schwarz Q, Ruhrberg C.
    Development; 2007 May 15; 134(10):1833-43. PubMed ID: 17428830
    [Abstract] [Full Text] [Related]

  • 20. Regulatory T Cell Insufficiency in Autoimmune Diabetes Is Driven by Selective Loss of Neuropilin-1 on Intraislet Regulatory T Cells.
    Grebinoski S, Pieklo G, Zhang Q, Visperas A, Cui J, Goulet J, Xiao H, Brunazzi EA, Cardello C, Herrada AA, Das J, Workman CJ, Vignali DAA.
    J Immunol; 2024 Sep 15; 213(6):779-794. PubMed ID: 39109924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.